Abstract
Aims
The objective of this study was to determine the educational needs of community pharmacists in Australia related to palliative cancer care, to guide the development of an online educational program for pharmacists.
Methods
Questionnaires were posted to a random sample of community pharmacies in Australia. The questionnaire sought information pertaining to pharmacists’: demographics; educational needs by rating the importance of learning more about 18 palliative cancer care topics and self-perceived level of knowledge of them; preference for format(s) for the program; willingness to participate in the program; and perception regarding their practice of palliative cancer care. Results were analysed using Statistical Package for the Social Sciences (SPSS) version 11.5 software.
Main results
A questionnaire return rate of 10.3% was achieved. The characteristics of respondents were reflective of community pharmacy practice in Australia when compared with the latest available labour force figures by the Australian Institute of Health and Welfare. Pharmacists rated all 18 topics as “important/essential”, and their level of knowledge of them as “poor/good”. Pharmacists preferred information provided in these formats: text (89.8%), case studies (80.6%) and multi-choice questions (69.4%). Most pharmacists (85.2%) indicated that they would participate in the program. The majority of pharmacists (71.3%) reported that they deliver palliative cancer care services; usually less-than-monthly (24.1%) or weekly (21.3%).
Conclusions
Educational needs of community pharmacists in palliative cancer care were identified. The information gathered will assist in guiding the development of an online educational program for pharmacists to improve their knowledge and skills in palliative cancer care.
Similar content being viewed by others
References
Australian Institute of Health and Welfare (2003) Pharmacy labour force to 2001. Australian Institute of Health and Welfare, Canberra
Boakes J, Gardner D, Yuen K, Doyle S (2000) General practitioner training in palliative care: an experiential approach. J Palliat Care 16:11–19
Clinical Oncology Society of Australia, The Cancer Council Australia, National Cancer Control Initiative (2002) Optimising cancer care in Australia. National Cancer Control Initiative, Melbourne
Diment MM, Evans BL (1995) Implementation of a pharmaceutical care practice model for palliative care. Can J Hosp Pharm 48:228–237
Doyle D, Hanks GWC, MacDonald N (1998) Oxford textbook of palliative medicine. Oxford University Press, New York
Edmondson H (2002) Primary care improving practice—community palliative care project. The NHS Executive Northern & Yorkshire, Durham. Available at: http://www.nyx/org.uk/modernprogrammes/cancerservices/goodpractice/may2002/communitypalliative.html (accessed May 2005)
Ferrell BR, Grant M, Ritchey KJ, Ropchan R, Rivera LM (1993) The pain resource nurse training program: a unique approach to pain management. J Pain Symptom Manage 8:549–556
Ferrell BR, McCaffery M (1997) Nurses’ knowledge about equianalgesia and opioid dosing. Cancer Nurs 20:201–212
Ferris FD, Von Gunten CF, Emanuel LL (2002) Ensuring competency in end-of-life care: controlling symptoms. BMC Palliat Care 1:5
Fins JJ, Nilson EG (2000) An approach to educating residents about palliative care and clinical ethics. Acad Med 75:662–665
Fox LS (1982) Pain management in the terminally ill cancer patient: an investigation of nurses’ attitudes, knowledge, and clinical practice. Mil Med 147:455–460
Furstenberg CT, Ahles TA, Whedon MB et al (1998) Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage 15:335–349
Greenwald BD, Narcessian EJ (1999) Opioids for managing patients with chronic pain: community pharmacists’ perspectives and concerns. J Pain Symptom Manage 17:369–375
Harris JM, Salasche SJ, Harris RB (1999) Using the internet to teach melanoma management guidelines to primary care physicians. J Eval Clin Pract 5:199–211
Hines C, Bingham J, Muirden N, Beavis M (1998) Evaluation of a cancer pain education program for general practitioners. Aust Fam Physician 27(Suppl 2):S70–S72
Hulsman RL, Wynand JGR, Janssen M, Winn AMW (1997) INTERACT-CANCER. The development and evaluation of a computer-assisted course on communication skills for medical specialists in oncology. Patient Educ Couns 30:129–141
Kerr A, Hall H, Kozub S (2002) Doing statistics with SPSS. Sage Publications, London
Kirk P, Kirk I, Kristjanson LJ (2004) What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ 328(7452):1343–1350
Lecouturier J, Jacoby A, Bradshaw C, Lovel T, Eccles M (1999) Lay carers’ satisfaction with community palliative care: results of a postal survey. South Tyneside MAAG palliative care study group. Palliat Med 13:275–283
McIntyre WJ, Hopkins DD, Wolfe JJ (2000) Assessing pharmacists’ knowledge of cancer pain. J Pharm Care Pain Symptom Control 8:75–83
Needham DS, Wong IC, Campion PD (2002) Evaluation of the effectiveness of UK community pharmacists’ interventions in community palliative care. Palliat Med 16:219–225
Pereira J, Bruera E, Quan H (2001) Palliative care on the net: an online survey of health care professionals. J Palliat Care 17:41–45
Polak M (2002) How community pharmacists have become involved in palliative care. Med Manag 6:7
Poole SG, Dooley MJ (2004) Off-label prescribing in oncology. Support Care Cancer 12:302–305
Raymond L (2003) Research study into the educational, training and support needs of general practitioners in palliative care. Australian Department of Health and Ageing, Canberra
Schuit KW, Bender W, Meijler WJ, Otter R, Meyboom-Dejong B, Sleijfer DT (1999) Learning effects of a workshop in palliative cancer care for general practitioners. J Cancer Educ 14:18–22
Trewin D (2004) Census of population and housing. Australia in profile: a regional analysis. Australia Bureau of Statistics, Canberra
Vernon J, Brien J, Dooley MJ, Spruyt O (1999) Multidisciplinary treatment paths and medication management of palliative care patients. Proc Aust Soc Clin Exp Pharmacol Toxicol 7:74
Wilkinson SM, Gambles M, Roberts A (2002) The essence of cancer care: the impact of training on nurses’ ability to communicate effectively. J Adv Nurs 40:731–738
Williams C, Aubin S, Harkin P, Cottrell D (2001) A randomized, controlled, single-blind trial of teaching provided by a computer-based multimedia package versus lecture. Med Educ 35:847–854
World Health Organization (2002) WHO definition of palliative care. World Health Organization, Geneva. Available at http://www.who.int/cancer/palliative/definition/en/ (accessed Feb 2005)
Writing Group for Therapeutic Guidelines: Palliative Care (2001) Therapeutic guidelines palliative care, version 1. Therapeutic Guidelines Limited, North Melbourne, Victoria
Acknowledgements
This study was funded by the Australian Government Department of Health and Ageing as part of the Third Community Pharmacy Agreement. The authors would like to thank the Pharmacy Guild of Australia for providing the database of a random sample of community pharmacies in Australia and the pharmacists for their valuable time and effort in completing the questionnaire.
Author information
Authors and Affiliations
Corresponding author
Appendix A
Appendix A
Questionnaire distributed to pharmacists
-
1.
What is your gender?
□Male □Female
-
2.
What will your age be on December 31, 2004?
□21–29 years
□30–39 years
□40–49 years
□50–59 years
□60 years and over
-
3.
What is the postcode of the pharmacy in which you work?
-
4.
How many years have you been practising as a registered pharmacist?
-
5.
The following table lists a number of topics related to palliative cancer care that could be included in an online educational program developed for community pharmacists. Indicate the importance to you of learning more about each of the topics by ticking the appropriate boxes below.
Topic
Not important
Of some importance
Important
Very important
Essential
Principles of Palliative Cancer Care
Causes of Cancer
Incidence and Prevalence of Cancer
Diagnosis and Staging of Cancer
Common Cancers: Risk Factors, Presentation, Treatments, Prognosis e.g. breast, colon, lung & skin cancers
Management of Cancer Pain
Management of Non-Pain Symptoms/Side Effects e.g. constipation, nausea, pressure sores
Palliative Cancer Treatments e.g. chemotherapy, radiotherapy
Long Term Complications of Chemotherapy e.g. effects on fertility
Handling of Cancer Emergencies e.g. hypercalcaemia, haemorrhage
Drug Interactions with Palliative Cancer Treatments
Complementary and Alternative Medicines used by patients with cancer e.g. homeopathic & herbal medicines, transcutaneous electrical nerve stimulation
Methods of Drug Administration in Palliative Cancer Care e.g. enteral & parenteral drug administration (nasogastric tubes, total parenteral nutrition), infusion pumps
Access to Palliative Cancer Medications e.g. Pharmaceutical Benefits Scheme and Special Access Scheme “issues”
Psychosocial Care of patients
Communicating with patients and families
Terminology Used in Palliative Care
Conducting Medicine Reviews for patients (at home, in residential aged care facilities and hospices)
Other (please describe)
Other (please describe)
Other (please describe)
-
6.
Indicate your level of knowledge of each of the following palliative cancer care topics by ticking the appropriate boxes in the table below.
Topic
Nil
Very Poor
Poor
Good
Excellent
Principles of Palliative Cancer Care
Causes of Cancer
Incidence and Prevalence of Cancer
Diagnosis and Staging of Cancer
Common Cancers: Risk Factors, Presentation, Treatments, Prognosis e.g. breast, colon, lung & skin cancers
Management of Cancer Pain
Management of Non-Pain Symptoms/Side Effects e.g. constipation, nausea, pressure sores
Palliative Cancer Treatments e.g. chemotherapy, radiotherapy
Long Term Complications of Chemotherapy e.g. effects on fertility
Handling of Cancer Emergencies e.g. hypercalcaemia, haemorrhage
Drug Interactions with Palliative Cancer Treatments
Complementary and Alternative Medicines used by patients with cancer e.g. homeopathic & herbal medicines, transcutaneous electrical nerve stimulation
Methods of Drug Administration in Palliative Cancer Care e.g. enteral & parenteral drug administration (nasogastric tubes, total parenteral nutrition), infusion pumps
Access to Palliative Cancer Medications e.g. Pharmaceutical Benefits Scheme and Special Access Scheme “issues”
Psychosocial Care of patients
Communicating with patients and families
Terminology Used in Palliative Care
Conducting Medicine Reviews for patients (at home, in residential aged care facilities and hospices)
Other (please describe)
Other (please describe)
Other (please describe)
-
7.
What format(s) would you find valuable to use in an online educational program in palliative cancer care? (You may tick more than one box)
□Information as text
Information that can be read on screen or printed for easier reading or later reference.
□Case studies
You are presented with problem-based and pharmacy practice-relevant scenarios to solve. Answers are provided at the end for reflection. Case studies are used to support the information provided as text and to put problems into a clinical and pharmacy-relevant context.
□Self-assessed multi-choice questionnaires
You are presented with questions that have up to five possible answers, from which you can choose only one which is correct. Immediate feedback is given about the response you choose. This enables you to test your knowledge and understanding of topics.
□Web-based Open discussion group
You may post questions to, or information for, your peers. This allows you to discuss problems, share your experiences and provide practice-based solutions for each other.
□Web-based Moderated discussion group
As above for the open discussion group, and additionally your questions are answered by a qualified person who has expertise in the area.
-
8.
Would you participate in an online educational program for community pharmacists in palliative cancer care (that would be free of cost) if offered to you?
□Yes [go to question 9]
□No [please indicate why, and go to question 10]
-
9.
If you would like to participate in the educational program that is developed to facilitate the role of community pharmacists in palliative cancer care, please write down your contact details on the separate slip provided with this questionnaire. Place the slip in one of the Reply Paid envelopes provided.
-
10.
-
a)
Are there occasions when you deliver palliative cancer care advice/services?
□Yes [go to question 10b]
□No [go to question 11]
-
b)
How often do you deliver palliative cancer care advice/services?
□Daily
□Weekly
□Fortnightly
□Monthly
□Less than monthly
-
a)
-
11.
Your comments are welcome.
Rights and permissions
About this article
Cite this article
Hussainy, S.Y., Beattie, J., Nation, R.L. et al. Palliative care for patients with cancer: what are the educational needs of community pharmacists?. Support Care Cancer 14, 177–184 (2006). https://doi.org/10.1007/s00520-005-0844-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0844-1